The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Pleased I stayed out having lost a lot on this share, hopefully, restart trial in 2019 share loses 1p a week nothing imminent very little trading really nothing to recommend them unless there's something in pipeline their not tell us about, and your right there will be an update full of promise before they ask for more funds.<br />will keep watching from the sidelines for now.
looks like he bought lanstead Capitols shares that's why trades not seen this looks like it will end up back in private hands with a few institutions providing no more decide to bail out, pleased I am out of it. Less stress
They sold one of the best hopes for $40,000,00 to survive administration. Went into a 9 month collaboration with French company with no Guarantee of anything should it look good to them they could probably but Redx out of their petty cash. we need to know what the cash burn is, are there to be more redundancies, will any of the large shareholder lose patience. Judging from previous experience the delay will be months not 2-3 more likely 6-8 minimum and with all other projects at earlier stages and shelved until a financial partner can be found, there is no good news coming out of redx anytime soon. I have sold the rest of my holding today as I have been averaging down since I bought into this stock I also hold one other stock on aim and that will be the last one I ever invest on in the AIM market. I find it hard to believe it could get any lower but all those who cashed in when they came out of administration must be feeling good with themselves. one more lot of bad news such as higher than expected cash burn more payoffs and this company is finished. Hence me finally giving in to a massive loss by my standards a little over 10 grand and finally realising I was Deluding myself with this company.
I am pleased I reduced my holding significantly a couple of weeks ago only wish I followed my own advice and sold a lot more. I still sit with 50,000 shares having sold 70,000 a couple of weeks ago it hurts as my average was around 24p when I rechecked but I will see if there is any bounce but I feel that is unlikely here as MM are totally in charge with this share not being very liquid mostly institutions holding real worry now is if one of them decide to cut their losses or Jon Moulton who has a large now practically worthless in his eyes. With months of delays and despite the RNS another fundraising is not going to be far away, I predicted 6-7p a couple of weeks ago happened a lot faster than expected I now see a very slow decline Hargreaves Lansdown are offering 4.3p to sell now as I write I just accepted, so am now totally out of this good luck to the brave souls who have the nerve to hold or average down but I see only one way with these and that down unless they become a takeover target in the present market I very much doubt it. I would to say its been a pleasure but at this moment in time it bloody painful. GOOD LUCK ALL
Listened not listed.
I was unable to obtain a price from Hargreaves Lansdown on Thursday or Friday only Kill and fill orders I ended up selling 20,000 at 10p was very unhappy with the price but I can see only further falls until some good news is released as it stands I see a price of about 6-7p over the next month I may sell my entire holding Monday or later next week if I see an increase in price just wish I sold at 23p instead of averaging down, should have listed to the more experienced investors who said sell and cut your loses.
Mentioned in Investors Chronicle today as one future-proof mining stock green lights all the way, you have to subscribe or I would have posted the piece.
I have today sold 1/3 of my Redx share been holding these a while took a big loss but needed the money for another share. Really disappointed with the share progression and lack of info from the board, but now I've sold watch them rocked.
Wish I had sold on relisting instead of averaging down but still feel there is a way to go on these shares, just have to hold your nerve and be patient I'm sure we will all feel better about these a year down the line GLA.
Thank for info Chiefton, I see what what you mean about Trolls on ADVFN put you right off shares but 1 or 2 decent contributors,
I hope your right and things are sorted, I am sitting on a very large loss with these shares. Can I ask where else you find threads on this company I can't find many, I use iii but iii as well but very rare anything on that site. I hope new directors and hopefully new CFO can sort something out. I would have thought if a company of this size would have known about the resignation of brokers they would have already had replacement in place to announce at the same time as the resignation. Lets hope for some good news soon.
Resignation of Nominated Adviser BNN Technology (AIM: BNN), a London-listed Chinese technology, content and services company, today announces that Strand Hanson Limited, its Nominated Adviser, has resigned with effect from close of business on 9 January 2018. The Company's ordinary shares are currently suspended from trading on AIM, and such suspension will remain in place. Should a replacement nominated adviser not be appointed prior to 9 February 2018, the Company's AIM admission will be cancelled.
I have noticed several large trades of 100,000 usually after 4.30pm close on several days at 23p+ so would assume they are buys, I would also expect several of the new directors to be buying a stake in the company, so far I have only seen Ian Ross buy 348,000. come on you new directors show us you have confidence in the company.
http://hardmanandco.com/docs/default-source/company-docs/redx-pharma--documents/13.11.17-streamlined-and-clean.pdf Some promising info but looks like one for the back burner, very pleased to see it return as I have been invested in these for 2 years, so showing a considerable lost. I have last week and today added to my holding to bring my average down to 30p from a original base of 48p but this looks like a long game. hopefully see some upward movement in the 1Q of the new year, fingers crossed.
Troubled biotech minnow Redx Pharma is poised to rejoin the AIM market tomorrow, as the chairman takes back control of the company and seeks to put an end to a torrid period. The Cheshire-based drugs maker, which shocked investors when it collapsed into administration in May, has been through an overhaul that involved cutting staff numbers and reshuffling its board. It is also on the hunt for a new chief executive after Neil Murray left the company. Redx fell into administration after Liverpool city council demanded repayment of a �2m loan it had made to the company in 2012. The shares were suspended and investors were left nursing heavy paper losses � and demanding changes from the new chairman, Iain Ross. Administrators at FRP Advisory were parachuted in to run the business, and sold off a key asset to secure its rescue. Now Ross, a turnaround specialist, is hoping to regain the trust of shareholders � among them veteran venture capitalist Jon Moulton. �We need to get back credibility,� said Ross, 63. �While there is a new board and management team, there is a credibility gap. We need to fill that.� The �2m loan, which was advanced to support an expansion in Liverpool, was called in by the council in May. The company had decided to move its headquarters to Cheshire rather than build a bigger facility on Merseyside. The demand for repayment sparked a war of words between Redx and the council, which allegedly refused to meet Ross. Since being appointed administrator, FRP has secured the $40m (�30m) sale of a pre-clinical cancer treatment to Loxo Oncology of the US � allowing Redx to repay its creditors and keeping it liquid until at least early 2019. Ross, who joined in May, wrote to shareholders over the weekend to lay out his plans for the company. Dominic Jackson, 36, who has worked in private equity since 2007, has been appointed chief financial officer. Peter Presland, 67, former chief executive of CE Health, will join the board as a non-executive director. Meanwhile, staff numbers have been cut from 85 to 38. The chairman is also streamlining its drug targets, focusing on fewer projects. Redx is poised to start clinical trials of a treatment for hard-to-reach cancers, early next year.
What allegations I have not seen post about anything, just looked through back post didn't notice anything.
Thu 24 Aug 2017 09:42 RNS Number: 8925O Redx Pharma plc 24 August 2017 24 August 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. REDX PHARMA PLC (in administration) ("Redx" or "the Company") Permission granted for distribution to Unsecured Creditors Redx, the drug discovery and development company, announces that Jason Baker and Miles Needham of FRP Advisory LLP, joint administrators of the Company and of its subsidiary, Redx Oncology Limited ("Oncology") (together, the "Companies") have been granted permission by the High Court to make a distribution to unsecured creditors of the Companies. The Joint Administrators will shortly be sending unsecured creditors notices of intended dividend, following which claims will be adjudicated and distributions made. All unsecured creditors will be paid in full (subject to adjudication). This is a significant step towards the anticipated rescue of the Companies as going concerns and the termination of the Administrations. A PDF copy of the Order is attached to this notice. Click on, or paste the following link into your web browser, to view the associated PDF document. http://www.rns-pdf.londonstockexchange.com/rns/8925O_-2017-8-24.pdf For further information, please contact: Redx Pharma Plc (in administration)
That's the big dilemma do you cut losses or average down in hope of a dead cat bounce, I am still unsure it will be a brave person investing more money with this company with it being under very tight scrutiny, any negative press comment likely to impact hard on the share price. To me, this is looking more like gambling than investing.
Trying to Guess the relisted share price is a pointless exercise as markets are very volatile to bad news, when we have full facts and the changes to the board of directors(which is an absolute must)we will be able to put a value on the company and price will settle there. If the pipeline is as good as we are led to believe any over devaluation could leave the company vulnerable to a takeover which might not be a bad thing for us investors in the long run. just my thoughts only thing that I have got out of this is that I no longer invest in AIM share other than those in my unit trusts.